These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8135033)

  • 1. [Calcium antagonists in therapy of arterial hypertension].
    Brandt D
    Wien Med Wochenschr; 1993; 143(19-20):510-3. PubMed ID: 8135033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The advantages of treatment with calcium blockers in arterial hypertension: a hope or a reality?].
    Dorobanţu M; Gherasim L
    Med Interna; 1993; 45(1-2):24-34. PubMed ID: 8081688
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension.
    Muiesan ML; Zulli R; Rizzoni D; Calebich S; Malerba M; Porteri E; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S104-5. PubMed ID: 8158296
    [No Abstract]   [Full Text] [Related]  

  • 4. [Differential therapy with calcium antagonists].
    Scholze JE
    Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arterial stiffness and pulse wave analysis].
    Baulmann J; Nürnberger J; Slany J; Schmieder R; Schmidt-Trucksäss A; Baumgart D; Cremerius P; Hess O; Mortensen K; Weber T
    Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 1():S4-14. PubMed ID: 20180172
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calcium antagonists in the treatment of arterial hypertension. Attempt at a differential therapy].
    Kiowski W
    Fortschr Med; 1984 Jul; 102(27-28):721-4. PubMed ID: 6479815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of regression of left ventricular hypertrophy after antihypertensive therapy. Comparative echo-Doppler study of ace inhibitors and calcium antagonists].
    Totteri A; Scopelliti G; Campanella G; Bertini M; Castro R; Pintus G; Jommi E
    Minerva Cardioangiol; 1993 Jun; 41(6):231-7. PubMed ID: 8361609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Place of calcium antagonists in the treatment of hypertension.
    Kiowski W
    Cor Vasa; 1990; 32(2 Suppl 1):2-11. PubMed ID: 2200638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Organ protection and regression of hypertension by calcium antagonists].
    Michel D
    Fortschr Med; 1991 Feb; 109(5):125-8. PubMed ID: 1828451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic considerations in the elderly hypertensive. The role of calcium channel blockers.
    Black HR
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):347S-354S. PubMed ID: 2078322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
    Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N
    Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer calcium antagonists for treatment of systemic hypertension.
    Singh NK
    J Assoc Physicians India; 1995 Apr; 43(4):277-81. PubMed ID: 8713269
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium antagonists in the treatment of arterial hypertension].
    Raczka A
    Pol Tyg Lek; 1983 Jan; 38(3):95-7. PubMed ID: 6866828
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists in hypertensive disease: experimental evidence for a new therapeutic concept.
    Kazda S; Garthoff B; Luckhaus G
    Postgrad Med J; 1983; 59 Suppl 2():78-83. PubMed ID: 6351044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium inhibitors and cardioprotection].
    Gosse P; Dallocchio M
    Therapie; 1989; 44(3):209-13. PubMed ID: 2528838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.